Our 19th century economic model is running on borrowed time. Finite resources are used to make things that we soon discard.

The clinical trial ecosystem is entering a phase of consolidation and reinvention driven by the collapse of boundaries between functions, data, and even companies themselves.

Noelle Acheson explains how on-chain vaults, born in decentralized finance, could shape the centralized banking of tomorrow.

As the robotics industry accelerates its transition toward large-scale commercialization, Shoucheng Holdings (0697.HK) has announced another significant milestone in its robotics investment and ...

Signet Jewelers (SIG) stays a Buy as Grow Brand Love lifts comps; lab-grown diamonds and services boost margins. Read here ...

Security leaders reveal 2026 priorities: supply chain resilience, AI governance, simplification, and collaborative threat ...

Biopharma enters 2026 amid continuing scientific progress and accelerating deal activity, yet its business model is under pressure across every facet of the value chain. Investors are taking note: ...

CEO Michael Intrator has recently extended his defense in CoreWeave’s adoption of a six-year useful life on its GPU assets.

CDMOs are re-evaluating a reliance on China and increasingly turning to nearshoring and friendshoring for supply chain ...

As global automotive manufacturers intensify efforts to reduce lifecycle emissions and source sustainable materials, European ...

A massive Amazonian fish yields the unique and once overlooked leather prized by luxury brands and Texas cowboys.

Introduction: The Myth of Abundance and the Reality of Data As concerns over global warming force a shift to battery ...